• Robin's News & Noticias
    Robin's News & Noticias
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • 2018 FIFA World Cup
    2018 FIFA World Cup
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

Mon07162018

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: The Law Offices of Howard G. Smith Reminds Investors of July 16th Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)


BENSALEM, Pa., July 13, 2018 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors of the July 16, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Prothena Corporation plc (“Prothena” or the “Company”) (NASDAQ:PRTA) securities between October 15, 2015 and April 20, 2018, inclusive (the “Class Period”). Prothena investors have until July 16, 2018 to file a lead plaintiff motion.
Investors suffering losses on their Prothena investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to @howardsmithlaw.com">This email address is being protected from spambots. You need JavaScript enabled to view it..On October 15, 2015, Prothena announced its late-stage Phase 2b “PRONTO” study and expansion of its Phase 1/2 clinical trial for the antibody NEOD001. On April 23, 2018, Prothena announced it was ending development of NEOD001 after its Phase 2b PRONTO trial failed to reach either its primary or secondary endpoints. On this news, shares of Prothena fell $25.34, or nearly 69%, to close at $11.50 on April 23, 2018, thereby injuring investors.The complaint filed in this class action alleges that, Defendants during the Class Period violated the federal securities laws by: (1) withholding relevant trial data showing that Prothena’s NEOD001, an antibody designed to treat amyloid light chain amyloidosis (“AL amyloidosis”), was not an effective treatment for AL amyloidosis; (2) making misleading comparisons of NEOD001’s “best response” rates against certain prior studies; and (3) touting that Prothena’s ongoing Phase 1/2 study of NEOD001 provided a strong basis for late-stage Phase 2b and Phase 3 studies of NEOD001, even though the full Phase 1/2 study data demonstrated that NEOD001 was not an effective treatment for AL amyloidosis.If you purchased shares of Prothena during the Class Period you may move the Court no later than July 16, 2018 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights ...


Posted: 2018-07-14 01:07:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: The Law Offices of Howard G. Smith Reminds Investors of July 16th Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA) | Globe NewsWire News Distribution Service - Newscast

The Law Offices of Howard G. Smith Reminds Investors of July 16th Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)

Mon, 16 Jul 2018 04:28:00 GMT

BENSALEM, Pa., -- Law Offices of Howard G. Smith reminds investors of the July 16, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Prothen...

CLASS ACTION UPDATE for PRTA and ATEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Wed, 11 Jul 2018 11:37:00 GMT

To learn more about the Prothena class action go to: http://www.zlk.com/pslra-d/prothena-corporation?wire=3. A10 Networks, Inc. (ATEN) Class Period: February 9, 2016 - January 30, 2018 Lead Plaintiff ...

UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PRTA, ATEN, QCOM, SBGL, and SYMC

Tue, 10 Jul 2018 13:07:00 GMT

NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have ... you have until the lead plaintiff deadline to request that the court appoint you as lead ...

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies - KSWO 7News | Breaking News, Weather and Sports

Tue, 10 Jul 2018 07:39:00 GMT

NEW YORK, July 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Prothena Corporation plc ("Prot...

PRTA ALERT: Rosen Law Firm Reminds Prothena Corporation plc Investors of Important Deadline in Case– PRTA

Sat, 23 Jun 2018 06:14:00 GMT

2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Prothena investors under the federal securities laws. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UN...

Related Bing Web Search

Lieff Cabraser Heimann & Bernstein - Champions of Justice ...

(Tue, 10 Jul 2018 07:02:00 GMT)

At Lieff Cabraser, we are your Champions for Justice in Personal Injury and Class Action Lawsuits.

volunteer work Archives - Lieff Cabraser Heimann ...

(Wed, 11 Jul 2018 06:04:00 GMT)

Prescription Opioid Drug Litigation - Cities and counties considering action to address the Opioid crisis should contact Lieff Cabraser partner Paulina do Amaral

Modern Home Builder - Modern Home Builder

(Tue, 10 Jul 2018 16:56:00 GMT)

Modern Home Builder Magazine - The magazine for North America's leaders in modern and custom home construction.

CELG Stock Price - Celgene Corp. Stock Quote (U.S.: Nasdaq ...

(Wed, 11 Jul 2018 20:23:00 GMT)

Celgene Corp. stock price, stock quotes and financial overviews from MarketWatch.

Press Releases - CNBC

(Wed, 11 Jul 2018 18:21:00 GMT)

Latest news hot off the presses from CNBC.

Related News Story Videos From Youtube

  • Sorry No Video Items Found




  • Blow Us A Whistle

    Comments (Whistles) Designed By Disqus




    Company Information

    Official Content Providers











    PRIVACY POLICY

    We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
    Copyright; 2008-2018 RobinsPost (The Bird's Eye View Company) All rights reserved.
    RobinsPost.com provides links to news sites based on their RSS feeds.
    All trademarks, copyrights, videos, photos and logos are owned by respective news sources.
    News stories, videos and live streams are from trusted sources.
    ROBINSPOST.COM Is Proudly Made In America.
    Where Quality, Safety and Service Comes First.